Product Description
Ceftriaxone & Tazobactam Injection 1.5 g combines the antibacterial properties of Ceftriaxone with the beta-lactamase inhibiting action of Tazobactam. This combination helps improve antibacterial effectiveness against susceptible microorganisms by protecting Ceftriaxone from enzymatic degradation.
The injection is intended for administration by qualified healthcare professionals through intramuscular (IM) or intravenous (IV) routes under medical supervision.
Ceftriaxone & Tazobactam Injection 1.5 g Supplier for Canberra, Australia
Premium Antibiotic Injection Manufactured in India
Ernest Oncology introduces Ceftriaxone & Tazobactam Injection 1.5 g, a high-quality sterile injectable antibiotic developed by combining Ceftriaxone, a third-generation cephalosporin antibiotic, with Tazobactam, a beta-lactamase inhibitor. Manufactured in India under WHO-GMP certified facilities, the formulation is produced using advanced pharmaceutical technology to deliver consistent quality, purity, and safety.
The medicine is intended for intramuscular (IM) or intravenous (IV) administration by qualified healthcare professionals according to approved clinical guidelines.
Product Overview
| Product Details | Information |
|---|---|
| Product Name | Ceftriaxone & Tazobactam Injection |
| Strength | 1.5 g |
| Active Ingredients | Ceftriaxone + Tazobactam |
| Dosage Form | Sterile Powder for Injection |
| Route of Administration | IM / IV |
| Therapeutic Category | Broad-Spectrum Antibiotic |
| Packaging | Sterile Export Packaging |
| Country of Origin | India |
Key Features
- Ceftriaxone and Tazobactam dual-action formulation
- Broad-spectrum antibacterial activity
- Sterile injectable preparation
- WHO-GMP certified manufacturing
- High pharmaceutical purity
- Stable pharmaceutical formulation
- Reliable batch consistency
- Export-quality packaging
- Manufactured using advanced technology
- International quality compliance
Description
Ernest Oncology supplies Ceftriaxone & Tazobactam Injection 1.5 g from India to Canberra, Australia. WHO-GMP manufactured sterile antibiotic injection with trusted pharmaceutical quality, advanced manufacturing, and international healthcare standards.
- Ceftriaxone & Tazobactam Injection 281.25 mg
- Ceftriaxone & Tazobactam Injection 562.5 mg
- Ceftriaxone & Tazobactam Injection 1.125 g
- Ceftriaxone & Tazobactam Injection 1.5 g
- Ceftriaxone & Tazobactam Injection 2.25 g
Written By
Chaitali H.
B. Pharma